GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 151 filers reported holding GW PHARMACEUTICALS PLC in Q3 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $15,903,000 | +4.1% | 73,319 | -44.6% | 0.01% | +11.1% |
| Q4 2020 | $15,281,000 | +63.1% | 132,402 | +37.5% | 0.01% | +50.0% |
| Q3 2020 | $9,371,000 | -16.0% | 96,258 | +5.9% | 0.01% | -33.3% |
| Q2 2020 | $11,153,000 | -16.2% | 90,883 | -40.2% | 0.01% | -25.0% |
| Q1 2020 | $13,315,000 | -16.5% | 152,058 | -0.3% | 0.01% | 0.0% |
| Q4 2019 | $15,953,000 | +4.4% | 152,571 | +14.8% | 0.01% | 0.0% |
| Q3 2019 | $15,287,000 | -8.7% | 132,901 | +36.8% | 0.01% | -7.7% |
| Q2 2019 | $16,746,000 | +9.7% | 97,136 | +7.3% | 0.01% | -13.3% |
| Q1 2019 | $15,262,000 | +51.6% | 90,538 | -12.4% | 0.02% | +36.4% |
| Q4 2018 | $10,065,000 | -38.4% | 103,339 | +9.3% | 0.01% | -26.7% |
| Q3 2018 | $16,334,000 | +79.9% | 94,556 | +45.4% | 0.02% | +66.7% |
| Q2 2018 | $9,077,000 | +0.1% | 65,038 | -19.2% | 0.01% | +28.6% |
| Q1 2018 | $9,068,000 | +12.7% | 80,481 | +32.0% | 0.01% | +16.7% |
| Q4 2017 | $8,049,000 | +37.9% | 60,965 | +6.0% | 0.01% | +50.0% |
| Q3 2017 | $5,837,000 | +36.6% | 57,511 | +35.0% | 0.00% | 0.0% |
| Q2 2017 | $4,272,000 | -84.9% | 42,614 | -81.7% | 0.00% | -84.0% |
| Q1 2017 | $28,229,000 | +23.2% | 233,419 | +13.9% | 0.02% | +19.0% |
| Q4 2016 | $22,905,000 | +57.0% | 204,957 | +86.5% | 0.02% | +50.0% |
| Q3 2016 | $14,586,000 | -22.0% | 109,893 | -46.2% | 0.01% | -26.3% |
| Q2 2016 | $18,708,000 | +121.7% | 204,302 | +74.7% | 0.02% | +111.1% |
| Q1 2016 | $8,439,000 | +42.0% | 116,960 | +36.7% | 0.01% | +80.0% |
| Q4 2015 | $5,941,000 | +18.6% | 85,554 | +56.0% | 0.01% | 0.0% |
| Q3 2015 | $5,011,000 | -3.6% | 54,848 | +29.7% | 0.01% | 0.0% |
| Q2 2015 | $5,196,000 | +83.0% | 42,303 | +35.8% | 0.01% | +66.7% |
| Q1 2015 | $2,839,000 | +818.8% | 31,147 | +580.7% | 0.00% | – |
| Q4 2014 | $309,000 | +116.1% | 4,576 | +158.4% | 0.00% | – |
| Q3 2014 | $143,000 | -74.6% | 1,771 | -66.3% | 0.00% | -100.0% |
| Q2 2014 | $563,000 | +650.7% | 5,256 | +317.5% | 0.00% | – |
| Q1 2014 | $75,000 | +7400.0% | 1,259 | +6894.4% | 0.00% | – |
| Q4 2013 | $1,000 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |